Speaker

Chris Haggard

Co-Founder & Chief Technical Officer, Axiom Therapeutics

Chris Haggard, Co-Founder & Chief Technical Officer at Axiom Therapeutics, spoke at 4th Covalent Drug Discovery & Development Summit (Boston, United States of America, 20–22 Oct 2026) in the session “Accelerating Covalent Drug Design by Improving Prediction of Binding Reactivity & Reducing Experimental Iteration Through Physics-Based & Data-Driven Models”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

4th Covalent Drug Discovery & Development Summit
20–22 Oct 2026Boston, United States of America
- SpeakerAccelerating Covalent Drug Design by Improving Prediction of Binding Reactivity & Reducing Experimental Iteration Through Physics-Based & Data-Driven Models

More speakers at 4th Covalent Drug Discovery & Development Summit

David Anderson
Executive Director, Aclaris Therapeutics
Sara Buhrlage
Associate Professor, Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute
Antony Burton
Associate Director, Chemical Biology & Proteomics, Dunad Therapeutics
Jianwei (John) Che
Core Director, Dana-Farber Cancer Institute
Julian Dopstadt
Director, Eli Lilly
Jay Duffner
Director & Head of Discovery Biology, Frontier Medicines

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Chris Haggard, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].